But when we found these antibodies that bound EBV in the spinal fluid, produced by the spinal fluid B cells, it made us ...

EBV is so prevalent that an estimated 90 percent of individuals will be infected by the time they are 20. Once inside the ...

is also excited by the possibilities these new insights into EBV’s role raise for developing new treatments. “The virus is smart,” he says. “It hides in B-cells, so targeting it using a ...

Although it is unclear what can trigger a reactivation of EBV, it may be due to an activation of B cells — a type of white blood cells in your immune system — in response to an unrelated ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

In animal studies, a similar vaccine candidate from ModeX generated neutralising antibodies in mice, ferrets, and nonhuman primates that inhibited EBV entry into both B cells and epithelial cells ...

A newly identified condition, called “post-vaccination syndrome” (PVS), appears to be linked to mRNA Covid vaccines.

A small number of people report chronic symptoms after receiving COVID-19 shots. A new study provides clues for further research.

--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV ... malignancies and B-cell driven ...